Logo image
Fluoroquinolones and the Risk of Achilles Tendon Disorders: Update on a Neglected Complication
Journal article   Open access   Peer reviewed

Fluoroquinolones and the Risk of Achilles Tendon Disorders: Update on a Neglected Complication

Alexandre Leme Godoy-Santos, Homero Bruschini, Jose Cury, Miguel Srougi, Cesar de Cesar-Netto, Lucas F Fonseca and Nicola Maffulli
Urology (Ridgewood, N.J.), Vol.113, pp.20-25
03/2018
DOI: 10.1016/j.urology.2017.10.017
PMID: 29074337
url
http://dx.doi.org/10.1016/j.urology.2017.10.017View
Open Access

Abstract

To evaluate the current evidence and to identify associated risk factors that increase the incidence of this complication. Fluoroquinolone (FQ) has been considered the first-line therapy for uncomplicated urinary infections. FQ has been associated with Achilles tendon disorders, especially during the first month of treatment. Data sources searched included PubMed, MEDLINE, and Scopus from January 1988 to June 2017. A total of 79 articles were used, with ciprofloxacin representing the most common drug. We found that male gender, advanced age, normal body mass index, chronic renal failure, and concurrent use of corticosteroids increase the risk of Achilles tendon disorders.
Severity of Illness Index Achilles Tendon - pathology Urinary Tract Infections - diagnosis Age Factors Follow-Up Studies Rupture, Spontaneous - chemically induced Rupture, Spontaneous - epidemiology Humans Middle Aged Tendinopathy - epidemiology Fluoroquinolones - therapeutic use Male Achilles Tendon - injuries Tendinopathy - chemically induced Case-Control Studies Fluoroquinolones - adverse effects Urinary Tract Infections - drug therapy Incidence Sex Factors Adult Female Retrospective Studies Tendinopathy - physiopathology

Details

Metrics

Logo image